Assignee
ROMARK LABORATORIES LC
US·17 granted patents·3 pending applications·41 citations·filing 2015–2021
Top patents by PatentIndex Score
20 records- 0192US9820975B2Compounds and methods for treating influenzaROMARK LABORATORIES LC·Filed 2016·Granted Nov 21, 2017·8 cites·12 claims
- 0291US10363243B2Compounds and methods for treating influenzaROMARK LABORATORIES LC·Filed 2017·Granted Jul 30, 2019·6 cites·31 claims
- 0389US10100023B2Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereofROMARK LABORATORIES LC·Filed 2015·Granted Oct 16, 2018·4 cites·31 claims
- 0489US9827227B2Controlled release pharmaceutical formulations of nitazoxanideROMARK LABORATORIES LC·Filed 2016·Granted Nov 28, 2017·6 cites·25 claims
- 0587US10358428B2Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereofROMARK LABORATORIES LC·Filed 2018·Granted Jul 23, 2019·2 cites·11 claims
- 0686USRE47786EHaloalkyl heteroaryl benzamide compoundsROMARK LABORATORIES LC·Filed 2018·Granted Dec 31, 2019·4 cites·21 claims
- 0785USRE46724EHaloalkyl heteroaryl benzamide compoundsROMARK LABORATORIES LC·Filed 2016·Granted Feb 20, 2018·4 cites·18 claims
- 0884US10577337B2Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereofROMARK LABORATORIES LC·Filed 2019·Granted Mar 3, 2020·1 cites·11 claims
- 0982US10383855B2Controlled release pharmaceutical formulations of nitozoxanideROMARK LABORATORIES LC·Filed 2017·Granted Aug 20, 2019·2 cites·10 claims
- 1082US10336058B2Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infectionsROMARK LABORATORIES LC·Filed 2018·Granted Jul 2, 2019·2 cites·14 claims
- 1181USRE47404EViral hepatitis treatmentROMARK LABORATORIES LC·Filed 2017·Granted May 28, 2019·2 cites·41 claims
- 1277US10912768B2Compounds and methods for treating influenzaROMARK LABORATORIES LC·Filed 2019·Granted Feb 9, 2021·0 cites·10 claims
- 1376US11850237B2Compounds and methods for treating influenzaROMARK LABORATORIES LC·Filed 2021·Granted Dec 26, 2023·0 cites·42 claims
- 1476US11426388B2Controlled release pharmaceutical formulations of nitazoxanideROMARK LABORATORIES LC·Filed 2019·Granted Aug 30, 2022·0 cites·11 claims
- 1575US10814612B2Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infectionsROMARK LABORATORIES LC·Filed 2019·Granted Oct 27, 2020·0 cites·14 claims
- 1664US2022125767A1Thiazolide compounds for treating viral infectionsROMARK LABORATORIES LC·Filed 2021·Application pending·0 cites
- 1760US11135202B2Thiazolide compounds for treating viral infectionsROMARK LABORATORIES LC·Filed 2017·Granted Oct 5, 2021·0 cites·10 claims
- 1858US2023330069A1Use of thiazolides against coronavirusesROMARK LABORATORIES LC·Filed 2021·Application pending·0 cites
- 1955US2023303504A1Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazineROMARK LABORATORIES LC·Filed 2021·Application pending·0 cites
- 2051US11173149B2Inhibition of protein disulfide-isomerase A3ROMARK LABORATORIES LC·Filed 2018·Granted Nov 16, 2021·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when ROMARK LABORATORIES LC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →